🇺🇸 FDA
Pipeline program

TransCon PTH

TransCon PTH TCP-201

Phase 2 small_molecule active

Quick answer

TransCon PTH for Hypoparathyroidism (HP) in Adults is a Phase 2 program (small_molecule) at Ascendis Pharma Bone Diseases A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
Ascendis Pharma Bone Diseases A/S
Indication
Hypoparathyroidism (HP) in Adults
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials